Authors
Latest:
Association Between Sustained Glycated Hemoglobin Control and Healthcare CostsTotal cost of care for patients whose glycated hemoglobin levels were
Latest:
Review of Outcomes Associated With Formulary Restrictions: Focus on Step TherapyAs healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Latest:
Cancer Screening: Let's Talk About ItOver the past 2 decades, the cancer death rate has drastically declined in the United States, falling 23% from its 1991 peak. This translates to 1.7 million lives saved.
Latest:
A New Monoclonal Antibody for R/R MM: Isatuximab-irfcIsatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.
Latest:
A Look Into 2011 Drug Utilization Trend and BeyondSignificant factors for 2011 prescription utilization include the recession, change in employment rate, new generic and brand launches, and changes in Baby Boomers' retirement plans.
Latest:
Managed Care Biologics and InjectablesPayer response to new entrants to the multiple sclerosis (MS) market is mixed as some believe that there remain meaningful, major unmet needs in the MS category, according to The Zitter Group's Spring 2011 Managed Care Biologics and Injectables Index.
Latest:
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.
Latest:
Sodium-Glucose Cotransporter-2 Inhibitors for Treating Type 2 DiabetesDiabetes is a complex disease affecting 29.1 million individuals in the United States.
Latest:
HIV Infection: The Future of TherapyApproximately 35 million individuals are currently living with HIV/AIDS.
Latest:
The Evolution of Accountable Care Organizations and the Role of PharmacistsWhen an ACO succeeds in both delivering high-quality care and spending health care dollars more wisely, it will share in the savings it achieves for the Medicare program.
Latest:
The Use of Authorizations by Specialty Pharmacies to Provide Protected Health Information to PharmaWhat are some of the pitfalls that a pharmacy needs to avoid when setting up a relationship with a pharma manufacturer to accept authorizations from individuals to release information to that manufacturer?
Latest:
Does Phenylephrine Really Control Allergic Rhinitis Symptoms?Allergic rhinitis is a condition that keeps noses and pharmacists running.
Latest:
Malignant Melanoma: The Implications of Cost for Stakeholder InnovationAn activity-based cost accounting model of melanoma care was used to identify key cost drivers and opportunities for stakeholder innovation.
Latest:
The Comparative Value of 3 Electronic Sources of Medication DataCombining medication history information from multiple sources improves the completeness and accuracy of the medication information.
Latest:
Predictive Analytics: A Case Study in Machine-Learning and Claims DatabasesA state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.
Latest:
Chronic Care Focus: Diagnosis and Treatment of COPD in Health SystemsControlling chronic obstructive pulmonary disease is a priority for health systems worldwide; recently updated guidelines provide strategies for diagnosis, management, and prevention.
Latest:
Mitigating Drug Diversion Risk: More Than Just Narcotics, Specialty Needs to Look at This Growing ProblemExpensive specialty drugs are a growing concern that are traditionally overlooked in drug diversion efforts.
Latest:
Aggressive, Early Treatment Slow MSDefining multiple sclerosis helps pinpoint what therapies work best for patients.
Latest:
Asembia’s 2018 Summit Continues to Enhance the Growth of Specialty PharmacyThe largest annual US health care conference dedicated to specialty pharmacy returns April 29 through May 2, 2018.
Latest:
Lifestyle Changes Could Mitigate Thousands of Cancers Each WeekSmoking and obesity account for a significant number of cancers worldwide.
Latest:
5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk FactorsPalonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.
Latest:
Preparing for New Rules on Hazardous Drug ManagementMany clinicians have been preparing for USP for a long time and are well on their way to compliance.
Latest:
Study: Intravenous Immunoglobulin Hastens Recovery of Early Onset Guillain-BarreIf IVIG is commenced within 2 weeks from the onset of Guillain-Barre syndrome it can hasten recovery as much as plasma exchange, study indicates.
Latest:
Patient Preference for Treatment Administration in Cystic FibrosisThis study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
